Entera Bio Ltd (ENTX) — Cash Flow-to-Debt Ratio
Entera Bio Ltd (ENTX) has a Cash Flow-to-Debt Ratio of -1.26x as of September 2025, meaning its operating cash flow of $-2.74 Million could theoretically repay -1% of its total liabilities ($2.17 Million) in one year. See Entera Bio Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Entera Bio Ltd Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Entera Bio Ltd across 10 annual periods. Also explore Entera Bio Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Entera Bio Ltd (2015–2024)
Year-by-year debt coverage analysis for Entera Bio Ltd. For market capitalisation and broader financial context, see Entera Bio Ltd stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -5.20x | $-6.82 Million | $1.31 Million | ▲ +1.8% |
| 2023 | -5.30x | $-7.31 Million | $1.38 Million | ▲ +41.8% |
| 2022 | -9.10x | $-12.50 Million | $1.37 Million | ▼ -243.7% |
| 2021 | -2.65x | $-9.06 Million | $3.42 Million | ▲ +44.5% |
| 2020 | -4.77x | $-10.56 Million | $2.21 Million | ▼ -156.0% |
| 2019 | -1.86x | $-8.92 Million | $4.78 Million | ▲ +38.6% |
| 2018 | -3.04x | $-9.80 Million | $3.23 Million | ▼ -2909.1% |
| 2017 | -0.10x | $-4.53 Million | $44.84 Million | ▼ -1.3% |
| 2016 | -0.10x | $-3.14 Million | $31.53 Million | ▲ +18.9% |
| 2015 | -0.12x | $-3.50 Million | $28.43 Million | — |